Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

Atefeh Khodakarami, Farhad Jadidi‐Niaragh, Atefeh Nazer et al.|Cell Communication and Signaling|2023

Cited by 16